![Pietro Scalfaro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pietro Scalfaro
Geen lopende functies
Profiel
Pietro Scalfaro served as a Director on the Supervisory Board of Agendia NV, Director of Diagnoplex SA, Non-Executive Director of Biocartis SA, and Chief Medical Officer of Immunexpress Pty Ltd. He received his undergraduate degree from the University of Lausanne in 1989.
Eerdere bekende functies van Pietro Scalfaro
| Bedrijven | Functie | Einde |
|---|---|---|
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Directeur/Bestuurslid | 01-04-2013 |
Immunexpress Pty Ltd.
 Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Hoofd Techniek/Wetenschap/O&O | - |
Diagnoplex SA
 Diagnoplex SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for colon cancer | Directeur/Bestuurslid | - |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Directeur/Bestuurslid | - |
Opleiding van Pietro Scalfaro
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
21
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Health Technology |
Diagnoplex SA
Diagnoplex SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for colon cancer | Health Technology |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
